Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gastric hydrochloric acid is a primary component of gastric juice, secreted by parietal cells in the stomach to facilitate the breakdown of proteins and provide an innate immune barrier against ingested microorganisms (StatPearls, 2023). Gastrointestinal gas bubbles are formed from swallowed air or the fermentation of food by gut microbiota, often becoming trapped in the gastrointestinal tract and causing symptoms of bloating and pressure (NIH, 2022). In pathological states such as gastroesophageal reflux disease (GERD) or functional dyspepsia, the acidity of the stomach can cause mucosal damage or pain, while excessive gas leads to abdominal distension. Pharmacological management of these targets typically involves non-systemic agents: antacids like calcium carbonate or magnesium hydroxide chemically neutralize the acid, while simethicone acts as a surfactant to break down gas bubbles (PubChem, 2024). These treatments provide symptomatic relief by altering the chemical and physical environment of the gastrointestinal lumen rather than targeting specific cellular receptors. This dual target approach is common in over-the-counter formulations designed to address both acid-related distress and gas-related discomfort simultaneously (FDA, 2021).
Antacids neutralize gastric hydrochloric acid through a chemical reaction, typically producing water and a salt, thereby increasing the gastric pH (StatPearls, 2023). Simethicone acts as an anti-foaming agent by decreasing the surface tension of gas bubbles in the stomach and intestines, allowing them to coalesce into larger bubbles that are more easily eliminated via belching or passing flatus (StatPearls, 2022).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastric hydrochloric acid and gastrointestinal gas bubbles.